| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Soft Tissue Neoplasms | 60 | 2023 | 1151 | 11.610 |
Why?
|
| Immunohistochemistry | 170 | 2024 | 11064 | 8.050 |
Why?
|
| Gastrointestinal Stromal Tumors | 30 | 2022 | 615 | 6.170 |
Why?
|
| Sarcoma | 43 | 2023 | 1786 | 5.470 |
Why?
|
| Succinate Dehydrogenase | 13 | 2022 | 145 | 3.450 |
Why?
|
| Gastrointestinal Neoplasms | 20 | 2023 | 951 | 3.280 |
Why?
|
| Proto-Oncogene Proteins c-kit | 30 | 2020 | 729 | 2.730 |
Why?
|
| Bone Neoplasms | 20 | 2023 | 2532 | 2.500 |
Why?
|
| Fibrosarcoma | 10 | 2023 | 308 | 2.460 |
Why?
|
| Gene Fusion | 9 | 2021 | 354 | 2.290 |
Why?
|
| Molecular Diagnostic Techniques | 10 | 2023 | 612 | 2.270 |
Why?
|
| Gene Rearrangement | 16 | 2023 | 1122 | 2.150 |
Why?
|
| Epithelioid Cells | 10 | 2021 | 60 | 2.150 |
Why?
|
| Hemangioendothelioma, Epithelioid | 5 | 2021 | 53 | 2.090 |
Why?
|
| Diagnosis, Differential | 71 | 2024 | 12968 | 2.040 |
Why?
|
| Adenocarcinoma | 32 | 2023 | 6310 | 1.860 |
Why?
|
| Histiocytoma, Benign Fibrous | 4 | 2019 | 63 | 1.810 |
Why?
|
| Nerve Sheath Neoplasms | 8 | 2021 | 167 | 1.740 |
Why?
|
| In Situ Hybridization, Fluorescence | 36 | 2023 | 2500 | 1.730 |
Why?
|
| Sarcoma, Synovial | 9 | 2020 | 151 | 1.730 |
Why?
|
| Stomach Neoplasms | 9 | 2023 | 1423 | 1.670 |
Why?
|
| Transcription Factors | 33 | 2023 | 12100 | 1.660 |
Why?
|
| Vascular Neoplasms | 6 | 2021 | 167 | 1.640 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 13 | 2023 | 1614 | 1.640 |
Why?
|
| Liposarcoma | 13 | 2023 | 283 | 1.610 |
Why?
|
| Leiomyosarcoma | 12 | 2022 | 424 | 1.600 |
Why?
|
| Oncogene Proteins, Fusion | 19 | 2023 | 1591 | 1.570 |
Why?
|
| Liposarcoma, Myxoid | 5 | 2023 | 60 | 1.520 |
Why?
|
| Mast Cells | 10 | 2023 | 1428 | 1.470 |
Why?
|
| Homeodomain Proteins | 12 | 2021 | 2414 | 1.460 |
Why?
|
| Neoplasm Proteins | 16 | 2021 | 3613 | 1.450 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 6 | 2024 | 77 | 1.450 |
Why?
|
| SOXB1 Transcription Factors | 9 | 2022 | 286 | 1.450 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 11 | 2022 | 367 | 1.350 |
Why?
|
| Neoplasms, Unknown Primary | 3 | 2022 | 102 | 1.330 |
Why?
|
| Skin Neoplasms | 18 | 2023 | 5797 | 1.330 |
Why?
|
| Rhabdomyosarcoma | 4 | 2021 | 361 | 1.280 |
Why?
|
| Carcinoma | 11 | 2023 | 2334 | 1.280 |
Why?
|
| Neurilemmoma | 5 | 2021 | 523 | 1.230 |
Why?
|
| Dermatofibrosarcoma | 5 | 2021 | 48 | 1.220 |
Why?
|
| Esophageal Neoplasms | 12 | 2021 | 1651 | 1.210 |
Why?
|
| Mastocytosis, Systemic | 5 | 2018 | 102 | 1.200 |
Why?
|
| Abdominal Neoplasms | 6 | 2014 | 286 | 1.190 |
Why?
|
| Solitary Fibrous Tumors | 5 | 2016 | 67 | 1.180 |
Why?
|
| Lipoma | 6 | 2023 | 292 | 1.130 |
Why?
|
| Mutation | 51 | 2024 | 29950 | 1.120 |
Why?
|
| Trans-Activators | 9 | 2021 | 2861 | 1.120 |
Why?
|
| Antibodies, Monoclonal | 21 | 2021 | 9196 | 1.120 |
Why?
|
| Barrett Esophagus | 9 | 2021 | 490 | 1.120 |
Why?
|
| Humans | 392 | 2024 | 760261 | 1.110 |
Why?
|
| Pathology, Molecular | 3 | 2019 | 330 | 1.060 |
Why?
|
| Neoplasms, Fibrous Tissue | 3 | 2022 | 20 | 1.060 |
Why?
|
| Dendritic Cell Sarcoma, Follicular | 4 | 2017 | 30 | 1.050 |
Why?
|
| Carcinoma, Acinar Cell | 3 | 2023 | 62 | 1.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 5 | 2020 | 728 | 1.010 |
Why?
|
| Predictive Value of Tests | 33 | 2023 | 15273 | 0.990 |
Why?
|
| Mesenchymoma | 2 | 2022 | 49 | 0.980 |
Why?
|
| Middle Aged | 196 | 2024 | 220175 | 0.980 |
Why?
|
| Histiocytic Sarcoma | 5 | 2019 | 41 | 0.960 |
Why?
|
| Sarcoma, Small Cell | 4 | 2023 | 17 | 0.950 |
Why?
|
| Repressor Proteins | 9 | 2021 | 2978 | 0.950 |
Why?
|
| Bile Duct Neoplasms | 4 | 2022 | 600 | 0.940 |
Why?
|
| Rhabdoid Tumor | 2 | 2020 | 210 | 0.940 |
Why?
|
| Pancreatic Neoplasms | 14 | 2023 | 5333 | 0.910 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2020 | 4494 | 0.910 |
Why?
|
| Cholangiocarcinoma | 4 | 2022 | 547 | 0.910 |
Why?
|
| Histones | 8 | 2020 | 2583 | 0.910 |
Why?
|
| Adult | 177 | 2024 | 219847 | 0.900 |
Why?
|
| Salivary Gland Neoplasms | 4 | 2023 | 304 | 0.890 |
Why?
|
| Male | 220 | 2024 | 359413 | 0.890 |
Why?
|
| Aged | 158 | 2024 | 168995 | 0.880 |
Why?
|
| Mucin-4 | 4 | 2016 | 33 | 0.870 |
Why?
|
| Calmodulin-Binding Proteins | 8 | 2022 | 232 | 0.870 |
Why?
|
| Female | 230 | 2024 | 391011 | 0.860 |
Why?
|
| Chondroblastoma | 2 | 2020 | 48 | 0.860 |
Why?
|
| Terminology as Topic | 5 | 2019 | 1534 | 0.830 |
Why?
|
| Mastocytosis | 4 | 2021 | 149 | 0.820 |
Why?
|
| Biopsy | 28 | 2023 | 6775 | 0.820 |
Why?
|
| Nuclear Proteins | 21 | 2021 | 5793 | 0.820 |
Why?
|
| Sarcoma, Kaposi | 2 | 2023 | 376 | 0.820 |
Why?
|
| Hemangiosarcoma | 6 | 2019 | 218 | 0.800 |
Why?
|
| Glomus Tumor | 1 | 2022 | 62 | 0.790 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 7 | 2021 | 698 | 0.790 |
Why?
|
| Young Adult | 75 | 2024 | 58673 | 0.780 |
Why?
|
| Pathology, Clinical | 3 | 2022 | 375 | 0.780 |
Why?
|
| DNA Mutational Analysis | 25 | 2022 | 4109 | 0.750 |
Why?
|
| Herpesvirus 8, Human | 1 | 2023 | 255 | 0.750 |
Why?
|
| Transcription Factor CHOP | 1 | 2021 | 68 | 0.750 |
Why?
|
| Stromal Cells | 7 | 2021 | 1327 | 0.750 |
Why?
|
| Neoplasm Recurrence, Local | 31 | 2022 | 9274 | 0.750 |
Why?
|
| Prognosis | 47 | 2023 | 29636 | 0.740 |
Why?
|
| Colorectal Neoplasms | 13 | 2024 | 6855 | 0.730 |
Why?
|
| Myofibroma | 3 | 2019 | 45 | 0.710 |
Why?
|
| Sensitivity and Specificity | 29 | 2024 | 14656 | 0.710 |
Why?
|
| Intestinal Mucosa | 9 | 2021 | 3023 | 0.710 |
Why?
|
| Osteosarcoma | 4 | 2022 | 898 | 0.690 |
Why?
|
| ras Proteins | 5 | 2019 | 1051 | 0.690 |
Why?
|
| Neoplastic Syndromes, Hereditary | 3 | 2017 | 243 | 0.680 |
Why?
|
| Neurofibrosarcoma | 1 | 2019 | 26 | 0.680 |
Why?
|
| Receptor, trkA | 3 | 2022 | 159 | 0.670 |
Why?
|
| Adolescent | 70 | 2023 | 87747 | 0.660 |
Why?
|
| Retinal Neoplasms | 1 | 2021 | 146 | 0.660 |
Why?
|
| Myoepithelioma | 4 | 2013 | 26 | 0.650 |
Why?
|
| Paranasal Sinus Neoplasms | 2 | 2018 | 241 | 0.650 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 3 | 2014 | 305 | 0.650 |
Why?
|
| Aged, 80 and over | 73 | 2022 | 58947 | 0.640 |
Why?
|
| Lung Neoplasms | 21 | 2022 | 13249 | 0.640 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 317 | 0.640 |
Why?
|
| Paired Box Transcription Factors | 4 | 2015 | 207 | 0.630 |
Why?
|
| Esophagogastric Junction | 1 | 2021 | 341 | 0.630 |
Why?
|
| Retinoblastoma | 1 | 2021 | 317 | 0.620 |
Why?
|
| WT1 Proteins | 2 | 2016 | 184 | 0.620 |
Why?
|
| Intestine, Small | 2 | 2021 | 1207 | 0.620 |
Why?
|
| DNA-Binding Proteins | 17 | 2023 | 9590 | 0.620 |
Why?
|
| Carcinoid Tumor | 3 | 2010 | 228 | 0.620 |
Why?
|
| Urticaria Pigmentosa | 2 | 2008 | 16 | 0.610 |
Why?
|
| Cytodiagnosis | 5 | 2017 | 432 | 0.610 |
Why?
|
| Hemangioendothelioma | 3 | 2019 | 111 | 0.610 |
Why?
|
| Retroperitoneal Neoplasms | 6 | 2015 | 329 | 0.610 |
Why?
|
| Pleural Neoplasms | 5 | 2022 | 609 | 0.600 |
Why?
|
| Uterine Neoplasms | 8 | 2022 | 1434 | 0.570 |
Why?
|
| Keratins | 6 | 2021 | 497 | 0.570 |
Why?
|
| Chromosomes, Human | 3 | 2017 | 442 | 0.560 |
Why?
|
| Myofibroblasts | 4 | 2016 | 207 | 0.560 |
Why?
|
| Cell Nucleus | 10 | 2021 | 2909 | 0.560 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 2015 | 2415 | 0.550 |
Why?
|
| Intestinal Neoplasms | 4 | 2023 | 311 | 0.550 |
Why?
|
| Electron Transport Complex II | 3 | 2013 | 53 | 0.550 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2016 | 73 | 0.550 |
Why?
|
| STAT6 Transcription Factor | 2 | 2013 | 193 | 0.540 |
Why?
|
| Eosinophilic Esophagitis | 4 | 2024 | 192 | 0.540 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2015 | 35 | 0.520 |
Why?
|
| Gastrointestinal Diseases | 3 | 2021 | 1189 | 0.520 |
Why?
|
| Endocrine System Diseases | 1 | 2018 | 251 | 0.520 |
Why?
|
| Neuroendocrine Tumors | 6 | 2023 | 649 | 0.520 |
Why?
|
| Nuclear Envelope | 2 | 2021 | 165 | 0.510 |
Why?
|
| Precancerous Conditions | 5 | 2022 | 978 | 0.510 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 4 | 2022 | 493 | 0.510 |
Why?
|
| Melanoma | 8 | 2023 | 5695 | 0.510 |
Why?
|
| Calcium-Binding Proteins | 3 | 2019 | 1066 | 0.500 |
Why?
|
| Sclerosis | 3 | 2014 | 210 | 0.500 |
Why?
|
| Neoplasms, Multiple Primary | 4 | 2014 | 586 | 0.500 |
Why?
|
| Granuloma, Plasma Cell | 4 | 2011 | 80 | 0.500 |
Why?
|
| Antibody Specificity | 5 | 2021 | 1061 | 0.500 |
Why?
|
| Child | 47 | 2023 | 79758 | 0.500 |
Why?
|
| Cell Differentiation | 10 | 2019 | 11480 | 0.490 |
Why?
|
| Hamartoma | 2 | 2009 | 235 | 0.490 |
Why?
|
| RNA-Binding Protein FUS | 2 | 2012 | 75 | 0.490 |
Why?
|
| Paraganglioma | 3 | 2014 | 142 | 0.490 |
Why?
|
| High-Throughput Nucleotide Sequencing | 17 | 2021 | 3618 | 0.480 |
Why?
|
| Tryptases | 4 | 2021 | 177 | 0.480 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 1483 | 0.480 |
Why?
|
| Neoplasms, Connective and Soft Tissue | 2 | 2020 | 34 | 0.470 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2013 | 490 | 0.470 |
Why?
|
| Biopsy, Fine-Needle | 9 | 2018 | 1111 | 0.470 |
Why?
|
| Mucous Membrane | 6 | 2023 | 657 | 0.470 |
Why?
|
| Adenocarcinoma, Mucinous | 5 | 2016 | 517 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2017 | 586 | 0.470 |
Why?
|
| Head and Neck Neoplasms | 6 | 2020 | 2880 | 0.460 |
Why?
|
| Membrane Glycoproteins | 4 | 2009 | 3731 | 0.460 |
Why?
|
| Matrix Attachment Region Binding Proteins | 2 | 2014 | 47 | 0.460 |
Why?
|
| Smooth Muscle Tumor | 2 | 2016 | 63 | 0.460 |
Why?
|
| Carcinoma, Neuroendocrine | 3 | 2023 | 346 | 0.460 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 226 | 0.460 |
Why?
|
| DNA, Neoplasm | 7 | 2013 | 1745 | 0.450 |
Why?
|
| Esophagus | 4 | 2011 | 1023 | 0.450 |
Why?
|
| Tissue Array Analysis | 9 | 2022 | 551 | 0.450 |
Why?
|
| Adenoma | 5 | 2012 | 2148 | 0.440 |
Why?
|
| Cell Dedifferentiation | 2 | 2013 | 122 | 0.440 |
Why?
|
| Histiocytosis, Langerhans-Cell | 4 | 2018 | 169 | 0.440 |
Why?
|
| Molecular Targeted Therapy | 5 | 2021 | 2805 | 0.440 |
Why?
|
| Skin | 7 | 2018 | 4468 | 0.440 |
Why?
|
| Staining and Labeling | 6 | 2017 | 1090 | 0.430 |
Why?
|
| Mast-Cell Sarcoma | 1 | 2012 | 46 | 0.430 |
Why?
|
| Testicular Neoplasms | 4 | 2022 | 800 | 0.430 |
Why?
|
| Seminoma | 3 | 2011 | 134 | 0.430 |
Why?
|
| Purine-Nucleoside Phosphorylase | 2 | 2023 | 28 | 0.420 |
Why?
|
| RNA-Binding Proteins | 5 | 2018 | 1892 | 0.420 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2017 | 549 | 0.420 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 323 | 0.410 |
Why?
|
| Neuroblastoma | 2 | 2018 | 1252 | 0.410 |
Why?
|
| Proto-Oncogene Proteins c-ets | 4 | 2019 | 311 | 0.410 |
Why?
|
| Neoplasms | 8 | 2021 | 22066 | 0.410 |
Why?
|
| DNA Methylation | 10 | 2019 | 4374 | 0.410 |
Why?
|
| Proto-Oncogene Proteins B-raf | 7 | 2018 | 2052 | 0.400 |
Why?
|
| Isocitrate Dehydrogenase | 6 | 2021 | 927 | 0.400 |
Why?
|
| Kidney Neoplasms | 5 | 2017 | 4312 | 0.400 |
Why?
|
| Cytosine | 1 | 2013 | 212 | 0.400 |
Why?
|
| Dendritic Cells, Follicular | 2 | 2009 | 50 | 0.400 |
Why?
|
| Colonic Polyps | 2 | 2009 | 550 | 0.400 |
Why?
|
| Lymph Nodes | 8 | 2021 | 3491 | 0.390 |
Why?
|
| Cyclin-Dependent Kinase 4 | 6 | 2022 | 556 | 0.390 |
Why?
|
| Immunoenzyme Techniques | 9 | 2016 | 1705 | 0.390 |
Why?
|
| Membrane Proteins | 10 | 2013 | 7854 | 0.380 |
Why?
|
| Dermatology | 1 | 2022 | 914 | 0.380 |
Why?
|
| Fibroma | 5 | 2016 | 190 | 0.380 |
Why?
|
| Piperazines | 11 | 2015 | 2520 | 0.380 |
Why?
|
| Mutant Proteins | 1 | 2013 | 492 | 0.380 |
Why?
|
| RNA-Binding Protein EWS | 6 | 2023 | 210 | 0.380 |
Why?
|
| Receptors, Steroid | 2 | 2023 | 154 | 0.380 |
Why?
|
| Gene Amplification | 7 | 2024 | 1085 | 0.370 |
Why?
|
| Carcinoma, Medullary | 1 | 2011 | 115 | 0.370 |
Why?
|
| Actins | 6 | 2022 | 2049 | 0.370 |
Why?
|
| NF-kappa B | 2 | 2019 | 2486 | 0.370 |
Why?
|
| Gastrointestinal Tract | 3 | 2023 | 830 | 0.370 |
Why?
|
| Cytogenetic Analysis | 5 | 2017 | 271 | 0.360 |
Why?
|
| Retinoblastoma Binding Proteins | 2 | 2021 | 102 | 0.360 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 5507 | 0.360 |
Why?
|
| In Situ Hybridization | 6 | 2021 | 1900 | 0.360 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2010 | 21 | 0.360 |
Why?
|
| Neoadjuvant Therapy | 6 | 2021 | 2811 | 0.360 |
Why?
|
| Retinoblastoma Protein | 3 | 2015 | 671 | 0.360 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2011 | 114 | 0.360 |
Why?
|
| Adenoma, Islet Cell | 1 | 2010 | 72 | 0.360 |
Why?
|
| Molecular Biology | 3 | 2023 | 581 | 0.350 |
Why?
|
| DNA Helicases | 4 | 2020 | 854 | 0.350 |
Why?
|
| Hemosiderosis | 1 | 2010 | 66 | 0.350 |
Why?
|
| Gene Expression Regulation, Neoplastic | 19 | 2021 | 8498 | 0.350 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2021 | 1115 | 0.350 |
Why?
|
| Melanoma-Specific Antigens | 4 | 2021 | 74 | 0.350 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2013 | 734 | 0.350 |
Why?
|
| Thyroid Neoplasms | 4 | 2022 | 2332 | 0.350 |
Why?
|
| Thoracic Neoplasms | 4 | 2020 | 265 | 0.340 |
Why?
|
| Stomach | 1 | 2014 | 695 | 0.340 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2022 | 2127 | 0.340 |
Why?
|
| Genetic Testing | 6 | 2021 | 3530 | 0.330 |
Why?
|
| Pyrimidines | 10 | 2013 | 3011 | 0.330 |
Why?
|
| Ovarian Neoplasms | 6 | 2024 | 4875 | 0.320 |
Why?
|
| Early Detection of Cancer | 2 | 2021 | 3215 | 0.320 |
Why?
|
| Chondrosarcoma | 4 | 2023 | 296 | 0.320 |
Why?
|
| Placenta Diseases | 2 | 2021 | 196 | 0.320 |
Why?
|
| Extremities | 5 | 2016 | 867 | 0.320 |
Why?
|
| Angiofibroma | 2 | 2023 | 55 | 0.320 |
Why?
|
| Histiocytic Disorders, Malignant | 3 | 2018 | 14 | 0.310 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2014 | 452 | 0.310 |
Why?
|
| Esophagectomy | 5 | 2021 | 469 | 0.310 |
Why?
|
| Schwann Cells | 1 | 2009 | 196 | 0.310 |
Why?
|
| Sarcoma, Clear Cell | 2 | 2023 | 72 | 0.310 |
Why?
|
| Adipocytes | 3 | 2017 | 1179 | 0.300 |
Why?
|
| Thyroid Diseases | 1 | 2011 | 386 | 0.300 |
Why?
|
| Child, Preschool | 18 | 2021 | 42034 | 0.300 |
Why?
|
| Muscle, Smooth | 3 | 2015 | 924 | 0.300 |
Why?
|
| Bile Ducts, Intrahepatic | 2 | 2022 | 296 | 0.300 |
Why?
|
| Carcinoma, Squamous Cell | 7 | 2020 | 4024 | 0.300 |
Why?
|
| Infant | 22 | 2020 | 36030 | 0.300 |
Why?
|
| Rectal Neoplasms | 4 | 2021 | 1151 | 0.290 |
Why?
|
| Osteoblasts | 1 | 2013 | 1142 | 0.290 |
Why?
|
| Chromosome Aberrations | 5 | 2019 | 1767 | 0.290 |
Why?
|
| Maxillary Sinus Neoplasms | 2 | 2018 | 39 | 0.290 |
Why?
|
| Neurothekeoma | 1 | 2007 | 4 | 0.290 |
Why?
|
| Fumarate Hydratase | 2 | 2018 | 52 | 0.290 |
Why?
|
| Mucins | 2 | 2012 | 568 | 0.290 |
Why?
|
| Reproducibility of Results | 15 | 2023 | 20048 | 0.290 |
Why?
|
| Neuroma | 1 | 2009 | 123 | 0.280 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 5 | 2016 | 1729 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2013 | 430 | 0.280 |
Why?
|
| Retrospective Studies | 45 | 2023 | 80301 | 0.280 |
Why?
|
| Phenotype | 14 | 2021 | 16543 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 4 | 2013 | 368 | 0.280 |
Why?
|
| DNA Mismatch Repair | 3 | 2021 | 429 | 0.280 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 4 | 2017 | 380 | 0.280 |
Why?
|
| S100 Proteins | 5 | 2012 | 218 | 0.270 |
Why?
|
| Genetic Predisposition to Disease | 14 | 2021 | 17766 | 0.270 |
Why?
|
| Sweat Gland Neoplasms | 2 | 2020 | 117 | 0.270 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2014 | 533 | 0.270 |
Why?
|
| Sirolimus | 3 | 2024 | 1548 | 0.270 |
Why?
|
| Neoplasm Staging | 19 | 2021 | 11141 | 0.270 |
Why?
|
| Liver Neoplasms | 8 | 2019 | 4317 | 0.270 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2020 | 4573 | 0.260 |
Why?
|
| Benzamides | 10 | 2013 | 1369 | 0.260 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2017 | 3217 | 0.260 |
Why?
|
| Hemangioma | 2 | 2022 | 727 | 0.260 |
Why?
|
| Diagnostic Imaging | 6 | 2016 | 3526 | 0.250 |
Why?
|
| Histiocytoma, Malignant Fibrous | 2 | 2019 | 55 | 0.250 |
Why?
|
| Lymphangioma, Cystic | 1 | 2005 | 34 | 0.250 |
Why?
|
| Translocation, Genetic | 6 | 2018 | 1388 | 0.250 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2023 | 487 | 0.250 |
Why?
|
| Antigens, CD34 | 8 | 2013 | 652 | 0.250 |
Why?
|
| Fasciitis | 1 | 2006 | 66 | 0.250 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 6 | 2013 | 693 | 0.240 |
Why?
|
| Follow-Up Studies | 25 | 2021 | 39254 | 0.240 |
Why?
|
| Disease-Free Survival | 15 | 2019 | 6830 | 0.240 |
Why?
|
| Treatment Outcome | 37 | 2024 | 64947 | 0.240 |
Why?
|
| Thyroid Gland | 1 | 2011 | 1169 | 0.240 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2023 | 1720 | 0.240 |
Why?
|
| Mastocytosis, Cutaneous | 2 | 2015 | 14 | 0.240 |
Why?
|
| Proton Pump Inhibitors | 3 | 2024 | 551 | 0.240 |
Why?
|
| Antigens, Neoplasm | 5 | 2023 | 1999 | 0.240 |
Why?
|
| Neuroectodermal Tumors, Primitive | 3 | 2013 | 136 | 0.230 |
Why?
|
| Neoplasm Metastasis | 14 | 2021 | 4891 | 0.230 |
Why?
|
| Angiomyolipoma | 1 | 2006 | 184 | 0.230 |
Why?
|
| Mucin-1 | 5 | 2009 | 539 | 0.230 |
Why?
|
| Cell Lineage | 4 | 2021 | 2525 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2019 | 995 | 0.230 |
Why?
|
| Muscle Proteins | 1 | 2009 | 1152 | 0.230 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2021 | 5640 | 0.230 |
Why?
|
| Sequence Analysis, RNA | 4 | 2021 | 2003 | 0.230 |
Why?
|
| Neurofibromatosis 1 | 1 | 2009 | 561 | 0.230 |
Why?
|
| Anus Neoplasms | 2 | 2019 | 329 | 0.230 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 1344 | 0.230 |
Why?
|
| Histiocytosis, Sinus | 2 | 2016 | 46 | 0.230 |
Why?
|
| Langerhans Cells | 2 | 2017 | 171 | 0.230 |
Why?
|
| Endometrial Neoplasms | 3 | 2020 | 1361 | 0.220 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2023 | 199 | 0.220 |
Why?
|
| Neuroectodermal Tumors | 1 | 2023 | 22 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 4409 | 0.220 |
Why?
|
| Genes, p53 | 4 | 2021 | 714 | 0.220 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2016 | 5230 | 0.220 |
Why?
|
| Photosensitizing Agents | 1 | 2007 | 616 | 0.220 |
Why?
|
| Laboratories | 2 | 2017 | 461 | 0.220 |
Why?
|
| Epithelium | 3 | 2014 | 1605 | 0.220 |
Why?
|
| Microsatellite Instability | 4 | 2016 | 715 | 0.210 |
Why?
|
| Annexins | 1 | 2022 | 39 | 0.210 |
Why?
|
| Desmin | 4 | 2015 | 99 | 0.210 |
Why?
|
| Peritoneal Neoplasms | 4 | 2014 | 706 | 0.210 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2020 | 421 | 0.210 |
Why?
|
| Cross Reactions | 4 | 2018 | 818 | 0.210 |
Why?
|
| Gene Expression | 6 | 2021 | 7592 | 0.210 |
Why?
|
| Gastrectomy | 2 | 2021 | 677 | 0.200 |
Why?
|
| Mesothelioma | 3 | 2022 | 806 | 0.200 |
Why?
|
| Synaptophysin | 1 | 2022 | 139 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-sis | 2 | 2021 | 256 | 0.200 |
Why?
|
| Oncogenes | 2 | 2019 | 1221 | 0.200 |
Why?
|
| Brain Neoplasms | 8 | 2021 | 8984 | 0.200 |
Why?
|
| Thymoma | 1 | 2023 | 187 | 0.200 |
Why?
|
| Claudins | 1 | 2022 | 115 | 0.200 |
Why?
|
| Colonic Neoplasms | 4 | 2019 | 2526 | 0.200 |
Why?
|
| Joint Diseases | 1 | 2006 | 458 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2022 | 2018 | 0.200 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2021 | 42 | 0.190 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2021 | 1890 | 0.190 |
Why?
|
| Cyclin D1 | 2 | 2017 | 453 | 0.190 |
Why?
|
| Carcinoma, Verrucous | 1 | 2021 | 27 | 0.190 |
Why?
|
| Oncogene Proteins | 3 | 2016 | 721 | 0.190 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2024 | 675 | 0.190 |
Why?
|
| Keratin-7 | 1 | 2021 | 55 | 0.190 |
Why?
|
| Inflammation | 6 | 2021 | 10757 | 0.190 |
Why?
|
| Photochemotherapy | 1 | 2007 | 819 | 0.190 |
Why?
|
| Karyotyping | 4 | 2011 | 1172 | 0.190 |
Why?
|
| Chondrosarcoma, Mesenchymal | 1 | 2020 | 12 | 0.190 |
Why?
|
| Neoplasms, Muscle Tissue | 2 | 2012 | 67 | 0.190 |
Why?
|
| PAX7 Transcription Factor | 2 | 2018 | 55 | 0.190 |
Why?
|
| Colonoscopy | 4 | 2014 | 1387 | 0.190 |
Why?
|
| Zebrafish Proteins | 2 | 2018 | 1006 | 0.180 |
Why?
|
| Chloride Channels | 3 | 2011 | 221 | 0.180 |
Why?
|
| Eccrine Porocarcinoma | 1 | 2020 | 18 | 0.180 |
Why?
|
| Endoscopy, Gastrointestinal | 7 | 2018 | 867 | 0.180 |
Why?
|
| Thymus Neoplasms | 1 | 2023 | 274 | 0.180 |
Why?
|
| Lymphadenitis | 1 | 2021 | 98 | 0.180 |
Why?
|
| Gene Expression Profiling | 9 | 2018 | 9388 | 0.180 |
Why?
|
| Germ-Line Mutation | 6 | 2018 | 1843 | 0.180 |
Why?
|
| Tumor Suppressor Protein p53 | 8 | 2022 | 2927 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2023 | 36247 | 0.180 |
Why?
|
| Pelvic Neoplasms | 1 | 2022 | 248 | 0.180 |
Why?
|
| Osteomalacia | 1 | 2020 | 56 | 0.180 |
Why?
|
| SOXE Transcription Factors | 2 | 2018 | 73 | 0.180 |
Why?
|
| Receptors, Somatostatin | 1 | 2021 | 135 | 0.170 |
Why?
|
| Appendix | 1 | 2021 | 110 | 0.170 |
Why?
|
| beta Catenin | 4 | 2021 | 1043 | 0.170 |
Why?
|
| Vaginal Neoplasms | 1 | 2020 | 105 | 0.170 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2021 | 93 | 0.170 |
Why?
|
| Survival Rate | 14 | 2021 | 12806 | 0.170 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2021 | 208 | 0.170 |
Why?
|
| Leiomyoma | 2 | 2016 | 654 | 0.170 |
Why?
|
| DNA | 2 | 2007 | 7236 | 0.170 |
Why?
|
| Liver Failure, Acute | 1 | 2021 | 181 | 0.170 |
Why?
|
| Loss of Heterozygosity | 3 | 2017 | 659 | 0.170 |
Why?
|
| Sucrose | 1 | 2020 | 156 | 0.170 |
Why?
|
| Chromatin | 3 | 2022 | 2939 | 0.170 |
Why?
|
| DNA Copy Number Variations | 3 | 2024 | 2008 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 9 | 2019 | 3618 | 0.170 |
Why?
|
| Fibromatosis, Aggressive | 3 | 2016 | 125 | 0.170 |
Why?
|
| MutS Homolog 2 Protein | 3 | 2019 | 195 | 0.170 |
Why?
|
| Hypophosphatemia | 1 | 2020 | 93 | 0.170 |
Why?
|
| Lymphatic Metastasis | 6 | 2018 | 2945 | 0.170 |
Why?
|
| Expert Testimony | 2 | 2019 | 361 | 0.170 |
Why?
|
| Cell Proliferation | 5 | 2017 | 10434 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2014 | 2823 | 0.160 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.160 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2021 | 633 | 0.160 |
Why?
|
| Diarrhea | 4 | 2014 | 1341 | 0.160 |
Why?
|
| Foot Diseases | 1 | 2020 | 147 | 0.160 |
Why?
|
| MART-1 Antigen | 3 | 2008 | 65 | 0.160 |
Why?
|
| Clusterin | 2 | 2009 | 71 | 0.160 |
Why?
|
| Colectomy | 1 | 2004 | 694 | 0.160 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2009 | 223 | 0.160 |
Why?
|
| Collagen Type VI | 1 | 2018 | 25 | 0.160 |
Why?
|
| Histiocytes | 2 | 2010 | 98 | 0.160 |
Why?
|
| Albumins | 1 | 2021 | 577 | 0.160 |
Why?
|
| Receptor, trkC | 1 | 2018 | 63 | 0.160 |
Why?
|
| Histiocytosis | 1 | 2018 | 40 | 0.160 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2019 | 198 | 0.160 |
Why?
|
| Dermatitis, Atopic | 2 | 2018 | 710 | 0.160 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2021 | 582 | 0.160 |
Why?
|
| Placenta | 3 | 2022 | 1701 | 0.160 |
Why?
|
| Carcinoma, Embryonal | 2 | 2009 | 37 | 0.160 |
Why?
|
| Intestines | 1 | 2007 | 1907 | 0.160 |
Why?
|
| Contractile Proteins | 1 | 2019 | 240 | 0.160 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 114 | 0.150 |
Why?
|
| Radioimmunotherapy | 1 | 1998 | 91 | 0.150 |
Why?
|
| Transcription Factor RelA | 1 | 2019 | 251 | 0.150 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 117 | 0.150 |
Why?
|
| Supratentorial Neoplasms | 1 | 2019 | 159 | 0.150 |
Why?
|
| Receptor, erbB-2 | 3 | 2024 | 2544 | 0.150 |
Why?
|
| Immunoblotting | 2 | 2020 | 1649 | 0.150 |
Why?
|
| Duodenum | 1 | 2021 | 486 | 0.150 |
Why?
|
| Neoplasm, Residual | 4 | 2017 | 1008 | 0.150 |
Why?
|
| Cell Line, Tumor | 11 | 2021 | 16905 | 0.150 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2020 | 5248 | 0.150 |
Why?
|
| Vulvar Neoplasms | 1 | 2020 | 265 | 0.150 |
Why?
|
| Neoplastic Stem Cells | 2 | 2018 | 1347 | 0.150 |
Why?
|
| Amino Acid Substitution | 2 | 2013 | 1737 | 0.150 |
Why?
|
| Dendritic Cell Sarcoma, Interdigitating | 1 | 2017 | 3 | 0.150 |
Why?
|
| Stillbirth | 1 | 2021 | 365 | 0.150 |
Why?
|
| Immunoprecipitation | 1 | 2020 | 877 | 0.150 |
Why?
|
| Vena Cava, Inferior | 2 | 2014 | 458 | 0.150 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2017 | 16 | 0.150 |
Why?
|
| Breast Neoplasms, Male | 1 | 2019 | 221 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 8 | 2019 | 6545 | 0.150 |
Why?
|
| Case-Control Studies | 8 | 2023 | 22041 | 0.150 |
Why?
|
| Immunoglobulin E | 3 | 2015 | 1493 | 0.150 |
Why?
|
| Intermediate Filament Proteins | 1 | 2018 | 263 | 0.150 |
Why?
|
| Lymph Node Excision | 3 | 2021 | 1305 | 0.150 |
Why?
|
| Angiolipoma | 1 | 2017 | 11 | 0.150 |
Why?
|
| Rabbits | 3 | 2020 | 4773 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2019 | 225 | 0.140 |
Why?
|
| RNA | 3 | 2023 | 2721 | 0.140 |
Why?
|
| Drug Administration Schedule | 2 | 2024 | 4900 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2017 | 3774 | 0.140 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2018 | 117 | 0.140 |
Why?
|
| California | 1 | 2021 | 1416 | 0.140 |
Why?
|
| Transcription, Genetic | 5 | 2021 | 7593 | 0.140 |
Why?
|
| Mycobacterium Infections | 1 | 2017 | 121 | 0.140 |
Why?
|
| Meningioma | 1 | 2006 | 1220 | 0.140 |
Why?
|
| Heredity | 1 | 2017 | 148 | 0.140 |
Why?
|
| Interleukin-2 | 3 | 1999 | 1890 | 0.140 |
Why?
|
| Time Factors | 13 | 2021 | 40133 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2018 | 11708 | 0.140 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2017 | 112 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2020 | 1056 | 0.140 |
Why?
|
| Antineoplastic Agents | 10 | 2014 | 13629 | 0.140 |
Why?
|
| Anaphylaxis | 2 | 2015 | 753 | 0.140 |
Why?
|
| Meningeal Neoplasms | 1 | 2006 | 1248 | 0.140 |
Why?
|
| Up-Regulation | 3 | 2017 | 4127 | 0.140 |
Why?
|
| HIV Infections | 1 | 2023 | 17159 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 7 | 2016 | 6067 | 0.140 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 2 | 2013 | 104 | 0.130 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2017 | 88 | 0.130 |
Why?
|
| Genotype | 5 | 2015 | 12959 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2020 | 2895 | 0.130 |
Why?
|
| Liver Diseases | 1 | 2005 | 1301 | 0.130 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2018 | 194 | 0.130 |
Why?
|
| Ependymoma | 1 | 2019 | 320 | 0.130 |
Why?
|
| Lung Injury | 1 | 2021 | 424 | 0.130 |
Why?
|
| Myeloproliferative Disorders | 2 | 2020 | 612 | 0.130 |
Why?
|
| Heartburn | 1 | 2016 | 68 | 0.130 |
Why?
|
| Histiocytic Necrotizing Lymphadenitis | 1 | 2016 | 26 | 0.130 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2018 | 617 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 679 | 0.130 |
Why?
|
| Ki-67 Antigen | 3 | 2022 | 631 | 0.130 |
Why?
|
| Cell Count | 3 | 2016 | 1838 | 0.130 |
Why?
|
| Leiomyomatosis | 1 | 2016 | 69 | 0.130 |
Why?
|
| Dacarbazine | 2 | 2009 | 560 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2017 | 20484 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 3 | 1999 | 3735 | 0.130 |
Why?
|
| Wasps | 1 | 2015 | 13 | 0.130 |
Why?
|
| Oncogene Fusion | 3 | 2021 | 81 | 0.130 |
Why?
|
| Wasp Venoms | 1 | 2015 | 21 | 0.130 |
Why?
|
| Protein Kinase C | 2 | 2014 | 1201 | 0.130 |
Why?
|
| Lymphokines | 1 | 2018 | 929 | 0.130 |
Why?
|
| Radiopharmaceuticals | 5 | 2018 | 2633 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 1173 | 0.120 |
Why?
|
| Colitis, Ulcerative | 2 | 2004 | 1919 | 0.120 |
Why?
|
| Asymptomatic Diseases | 2 | 2018 | 582 | 0.120 |
Why?
|
| Axonemal Dyneins | 1 | 2014 | 23 | 0.120 |
Why?
|
| Boston | 4 | 2021 | 9282 | 0.120 |
Why?
|
| Risk Assessment | 7 | 2022 | 24086 | 0.120 |
Why?
|
| Human papillomavirus 18 | 1 | 2015 | 126 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2015 | 79 | 0.120 |
Why?
|
| Mitotic Index | 3 | 2013 | 161 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1137 | 0.120 |
Why?
|
| Insect Bites and Stings | 1 | 2015 | 70 | 0.120 |
Why?
|
| Esophageal Stenosis | 1 | 2016 | 193 | 0.120 |
Why?
|
| World Health Organization | 1 | 2021 | 1319 | 0.120 |
Why?
|
| Germ Cells | 1 | 2018 | 635 | 0.120 |
Why?
|
| Wilms Tumor | 1 | 2017 | 376 | 0.120 |
Why?
|
| Indocyanine Green | 1 | 2016 | 236 | 0.120 |
Why?
|
| Quality Control | 1 | 2017 | 827 | 0.120 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2018 | 581 | 0.110 |
Why?
|
| Pedigree | 3 | 2017 | 4577 | 0.110 |
Why?
|
| Metaplasia | 4 | 2021 | 320 | 0.110 |
Why?
|
| Microarray Analysis | 2 | 2014 | 747 | 0.110 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 673 | 0.110 |
Why?
|
| Xanthomatosis | 1 | 2013 | 32 | 0.110 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 507 | 0.110 |
Why?
|
| Bradyrhizobium | 1 | 2013 | 16 | 0.110 |
Why?
|
| Genes, Retinoblastoma | 1 | 2014 | 125 | 0.110 |
Why?
|
| Colitis | 2 | 2013 | 1229 | 0.110 |
Why?
|
| Human papillomavirus 16 | 1 | 2015 | 266 | 0.110 |
Why?
|
| Fetal Proteins | 1 | 2014 | 97 | 0.110 |
Why?
|
| Intestinal Polyposis | 1 | 2013 | 42 | 0.110 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2013 | 45 | 0.110 |
Why?
|
| Eosinophils | 2 | 2016 | 946 | 0.110 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2014 | 103 | 0.110 |
Why?
|
| HMGA2 Protein | 2 | 2011 | 102 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2005 | 697 | 0.110 |
Why?
|
| Osteoblastoma | 1 | 2013 | 24 | 0.110 |
Why?
|
| Algorithms | 4 | 2021 | 13967 | 0.110 |
Why?
|
| Paraffin Embedding | 2 | 2013 | 302 | 0.110 |
Why?
|
| Rectum | 2 | 2017 | 896 | 0.110 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2018 | 2007 | 0.110 |
Why?
|
| Genital Neoplasms, Male | 1 | 2013 | 68 | 0.110 |
Why?
|
| Survival Analysis | 8 | 2018 | 10185 | 0.110 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2015 | 220 | 0.110 |
Why?
|
| Oligodendroglioma | 1 | 2014 | 279 | 0.110 |
Why?
|
| 5-Methylcytosine | 1 | 2013 | 146 | 0.100 |
Why?
|
| Breast Neoplasms | 7 | 2019 | 21065 | 0.100 |
Why?
|
| Sarcoma, Myeloid | 1 | 2012 | 51 | 0.100 |
Why?
|
| Osteoma, Osteoid | 1 | 2013 | 90 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3086 | 0.100 |
Why?
|
| Blister | 1 | 2012 | 87 | 0.100 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2021 | 1356 | 0.100 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 896 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3206 | 0.100 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2012 | 44 | 0.100 |
Why?
|
| Mice | 21 | 2024 | 81216 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2019 | 1655 | 0.100 |
Why?
|
| Base Pair Mismatch | 1 | 2012 | 92 | 0.100 |
Why?
|
| Retroperitoneal Space | 1 | 2012 | 173 | 0.100 |
Why?
|
| Animals | 25 | 2024 | 167940 | 0.100 |
Why?
|
| Abdominal Pain | 2 | 2016 | 1064 | 0.100 |
Why?
|
| Fibrinogen | 1 | 2015 | 887 | 0.100 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2013 | 1790 | 0.100 |
Why?
|
| Pouchitis | 1 | 2012 | 64 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2018 | 789 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 256 | 0.100 |
Why?
|
| Endothelial Cells | 4 | 2022 | 3537 | 0.100 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 943 | 0.100 |
Why?
|
| Colon | 2 | 2013 | 1788 | 0.100 |
Why?
|
| T-Box Domain Proteins | 1 | 2014 | 469 | 0.090 |
Why?
|
| Gene Dosage | 5 | 2017 | 1218 | 0.090 |
Why?
|
| Exons | 3 | 2013 | 2391 | 0.090 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2011 | 83 | 0.090 |
Why?
|
| Receptors, CCR4 | 1 | 2011 | 77 | 0.090 |
Why?
|
| Disease Progression | 8 | 2018 | 13505 | 0.090 |
Why?
|
| Gastric Mucosa | 1 | 2014 | 599 | 0.090 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2021 | 3531 | 0.090 |
Why?
|
| Colonic Pouches | 1 | 2012 | 122 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2017 | 777 | 0.090 |
Why?
|
| Jejunum | 1 | 2013 | 472 | 0.090 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2016 | 740 | 0.090 |
Why?
|
| Chordoma | 1 | 2014 | 346 | 0.090 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2011 | 151 | 0.090 |
Why?
|
| Carcinoma, Merkel Cell | 2 | 2018 | 321 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2016 | 5644 | 0.090 |
Why?
|
| HMGB Proteins | 2 | 2007 | 44 | 0.090 |
Why?
|
| Colonic Diseases | 1 | 2012 | 200 | 0.090 |
Why?
|
| Virus Diseases | 1 | 2017 | 721 | 0.090 |
Why?
|
| Co-Repressor Proteins | 1 | 2011 | 191 | 0.090 |
Why?
|
| Periodicals as Topic | 1 | 2022 | 1470 | 0.090 |
Why?
|
| Diagnostic Errors | 2 | 2011 | 1266 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2013 | 380 | 0.090 |
Why?
|
| Radiotherapy | 2 | 2016 | 1505 | 0.090 |
Why?
|
| Cilia | 1 | 2014 | 492 | 0.090 |
Why?
|
| Antibodies, Neoplasm | 1 | 2012 | 280 | 0.090 |
Why?
|
| Advisory Committees | 1 | 2015 | 789 | 0.090 |
Why?
|
| Antigens, CD | 2 | 2014 | 4002 | 0.090 |
Why?
|
| Bacteria | 1 | 2021 | 2196 | 0.090 |
Why?
|
| Opportunistic Infections | 1 | 2013 | 377 | 0.090 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2020 | 3606 | 0.090 |
Why?
|
| Liver | 2 | 2017 | 7512 | 0.090 |
Why?
|
| Sarcoidosis | 1 | 2016 | 520 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2020 | 2918 | 0.090 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2012 | 190 | 0.090 |
Why?
|
| Receptors, Estrogen | 3 | 2021 | 2202 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 495 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2011 | 311 | 0.090 |
Why?
|
| Cell Respiration | 1 | 2010 | 202 | 0.090 |
Why?
|
| Deglutition Disorders | 1 | 2016 | 627 | 0.090 |
Why?
|
| Appendectomy | 1 | 2013 | 431 | 0.090 |
Why?
|
| Polyps | 1 | 2012 | 197 | 0.090 |
Why?
|
| Cohort Studies | 7 | 2021 | 41317 | 0.090 |
Why?
|
| Pheochromocytoma | 1 | 2012 | 328 | 0.090 |
Why?
|
| Esophagitis, Peptic | 1 | 2010 | 76 | 0.090 |
Why?
|
| Keratin-6 | 1 | 2009 | 18 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2010 | 276 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2011 | 347 | 0.090 |
Why?
|
| Astrocytoma | 1 | 2014 | 775 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2021 | 1938 | 0.090 |
Why?
|
| Chromosomes, Human, Y | 1 | 2011 | 161 | 0.090 |
Why?
|
| Keratin-5 | 1 | 2009 | 45 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 313 | 0.090 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2020 | 1401 | 0.080 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2011 | 111 | 0.080 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2011 | 180 | 0.080 |
Why?
|
| Giant Cell Tumors | 1 | 2009 | 90 | 0.080 |
Why?
|
| Ossification, Heterotopic | 1 | 2012 | 235 | 0.080 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 2 | 2008 | 259 | 0.080 |
Why?
|
| Pancreatitis | 1 | 2016 | 1100 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 4717 | 0.080 |
Why?
|
| Carcinoma, Small Cell | 2 | 2018 | 416 | 0.080 |
Why?
|
| Myeloid Cells | 2 | 2021 | 821 | 0.080 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2013 | 387 | 0.080 |
Why?
|
| Pyrazoles | 2 | 2010 | 1992 | 0.080 |
Why?
|
| Receptors, Complement 3b | 1 | 2009 | 135 | 0.080 |
Why?
|
| Receptors, Complement 3d | 1 | 2009 | 117 | 0.080 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2011 | 305 | 0.080 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2009 | 84 | 0.080 |
Why?
|
| Immune System Diseases | 1 | 2011 | 258 | 0.080 |
Why?
|
| Genes, p16 | 2 | 2021 | 159 | 0.080 |
Why?
|
| Esophagoscopy | 3 | 2018 | 391 | 0.080 |
Why?
|
| Subcutaneous Tissue | 1 | 2009 | 132 | 0.080 |
Why?
|
| Face | 1 | 2014 | 1017 | 0.080 |
Why?
|
| Heart Neoplasms | 1 | 2012 | 360 | 0.080 |
Why?
|
| Hyalin | 1 | 2008 | 34 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 426 | 0.080 |
Why?
|
| Chromogranins | 1 | 2009 | 161 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2010 | 635 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2011 | 663 | 0.080 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2013 | 576 | 0.080 |
Why?
|
| Stem Cells | 1 | 2021 | 3525 | 0.080 |
Why?
|
| Epitopes | 1 | 2014 | 2506 | 0.080 |
Why?
|
| Glioma | 2 | 2021 | 3420 | 0.080 |
Why?
|
| Proportional Hazards Models | 5 | 2017 | 12532 | 0.080 |
Why?
|
| Incidental Findings | 2 | 2012 | 698 | 0.080 |
Why?
|
| Adaptive Immunity | 1 | 2013 | 724 | 0.080 |
Why?
|
| Food Hypersensitivity | 2 | 2013 | 692 | 0.080 |
Why?
|
| Cell Membrane | 2 | 2007 | 3683 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 1914 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2020 | 2041 | 0.070 |
Why?
|
| Ectodermal Dysplasia | 1 | 2009 | 106 | 0.070 |
Why?
|
| Isoenzymes | 3 | 2013 | 1690 | 0.070 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2009 | 619 | 0.070 |
Why?
|
| Gardner Syndrome | 1 | 2007 | 3 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2594 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2009 | 251 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2018 | 3076 | 0.070 |
Why?
|
| Ankle | 1 | 2010 | 350 | 0.070 |
Why?
|
| Plasma Cells | 1 | 2011 | 592 | 0.070 |
Why?
|
| Positron-Emission Tomography | 6 | 2014 | 6457 | 0.070 |
Why?
|
| Genome, Human | 2 | 2017 | 4416 | 0.070 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2009 | 550 | 0.070 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2009 | 195 | 0.070 |
Why?
|
| Respiratory System | 2 | 2021 | 554 | 0.070 |
Why?
|
| RNA, Viral | 1 | 2015 | 2837 | 0.070 |
Why?
|
| Combined Modality Therapy | 6 | 2016 | 8551 | 0.070 |
Why?
|
| Embryonic Stem Cells | 3 | 2013 | 1262 | 0.070 |
Why?
|
| Mannose-Binding Lectins | 1 | 2007 | 96 | 0.070 |
Why?
|
| Allergens | 2 | 2013 | 1399 | 0.070 |
Why?
|
| Risk Factors | 10 | 2021 | 74269 | 0.070 |
Why?
|
| Receptors, Fc | 1 | 2010 | 534 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 2011 | 344 | 0.070 |
Why?
|
| Neurofilament Proteins | 1 | 2009 | 333 | 0.070 |
Why?
|
| United States | 10 | 2021 | 72363 | 0.070 |
Why?
|
| Immunization | 1 | 2011 | 1228 | 0.070 |
Why?
|
| Fetal Blood | 1 | 2013 | 1343 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 2178 | 0.070 |
Why?
|
| Brachytherapy | 1 | 2014 | 1240 | 0.070 |
Why?
|
| Bone and Bones | 2 | 2017 | 2560 | 0.070 |
Why?
|
| DNA Repair Enzymes | 1 | 2008 | 345 | 0.070 |
Why?
|
| Cytogenetics | 2 | 2021 | 198 | 0.070 |
Why?
|
| Papillomavirus Infections | 2 | 2015 | 1600 | 0.070 |
Why?
|
| Autopsy | 2 | 2020 | 1007 | 0.070 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 84 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2015 | 2058 | 0.070 |
Why?
|
| Synovial Membrane | 1 | 2009 | 524 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2021 | 26168 | 0.070 |
Why?
|
| Gene Deletion | 3 | 2021 | 2668 | 0.070 |
Why?
|
| Germinoma | 1 | 2006 | 132 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2021 | 6540 | 0.070 |
Why?
|
| Vaccination | 2 | 2022 | 3360 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2013 | 2918 | 0.060 |
Why?
|
| Thyroidectomy | 1 | 2011 | 903 | 0.060 |
Why?
|
| Registries | 2 | 2019 | 8449 | 0.060 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2010 | 475 | 0.060 |
Why?
|
| Genes, erbB-1 | 1 | 2006 | 160 | 0.060 |
Why?
|
| Hemangiopericytoma | 1 | 2006 | 71 | 0.060 |
Why?
|
| Pyridines | 3 | 2015 | 2877 | 0.060 |
Why?
|
| Necrosis | 2 | 2022 | 1612 | 0.060 |
Why?
|
| Receptors, Fibroblast Growth Factor | 2 | 2019 | 191 | 0.060 |
Why?
|
| Exocrine Glands | 1 | 2005 | 46 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 14482 | 0.060 |
Why?
|
| Myxoma | 1 | 2006 | 114 | 0.060 |
Why?
|
| Immunophenotyping | 4 | 2016 | 1870 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2018 | 5120 | 0.060 |
Why?
|
| Caveolin 1 | 1 | 2007 | 257 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2013 | 6226 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 5784 | 0.060 |
Why?
|
| Carcinoma in Situ | 1 | 2011 | 796 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2009 | 1518 | 0.060 |
Why?
|
| Pyrroles | 2 | 2012 | 1137 | 0.060 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2009 | 557 | 0.060 |
Why?
|
| Signal Transduction | 6 | 2018 | 23363 | 0.060 |
Why?
|
| Genomics | 2 | 2018 | 5790 | 0.060 |
Why?
|
| Adenomatous Polyposis Coli Protein | 2 | 2017 | 180 | 0.060 |
Why?
|
| Salvage Therapy | 1 | 2011 | 1266 | 0.060 |
Why?
|
| DNA Glycosylases | 2 | 2017 | 124 | 0.060 |
Why?
|
| Mutation, Missense | 2 | 2012 | 2563 | 0.060 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2024 | 59 | 0.060 |
Why?
|
| Proteins | 1 | 2019 | 6030 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 1899 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 2250 | 0.060 |
Why?
|
| Lectins, C-Type | 1 | 2007 | 591 | 0.060 |
Why?
|
| Islets of Langerhans | 1 | 2010 | 1341 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2023 | 89 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 1613 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2022 | 2804 | 0.060 |
Why?
|
| Adnexal Diseases | 1 | 2024 | 104 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2016 | 4938 | 0.050 |
Why?
|
| Omeprazole | 1 | 2024 | 112 | 0.050 |
Why?
|
| Indoles | 2 | 2012 | 1830 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2010 | 1155 | 0.050 |
Why?
|
| Pancreatectomy | 2 | 2018 | 809 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2011 | 1811 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2716 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2297 | 0.050 |
Why?
|
| Adoptive Transfer | 2 | 2018 | 825 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 1601 | 0.050 |
Why?
|
| Recurrence | 2 | 2016 | 8487 | 0.050 |
Why?
|
| Immunoglobulin G | 2 | 2013 | 4546 | 0.050 |
Why?
|
| DNA Repair | 1 | 2012 | 2039 | 0.050 |
Why?
|
| Contrast Media | 5 | 2014 | 5301 | 0.050 |
Why?
|
| Government Agencies | 1 | 2022 | 161 | 0.050 |
Why?
|
| Prevalence | 4 | 2021 | 15687 | 0.050 |
Why?
|
| Remission Induction | 2 | 2024 | 2394 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2022 | 183 | 0.050 |
Why?
|
| Azepines | 2 | 2014 | 330 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2013 | 2877 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 1999 | 6131 | 0.050 |
Why?
|
| Mediastinal Neoplasms | 1 | 2005 | 402 | 0.050 |
Why?
|
| Smad4 Protein | 1 | 2023 | 191 | 0.050 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2021 | 24 | 0.050 |
Why?
|
| Mitosis | 1 | 2007 | 1193 | 0.050 |
Why?
|
| Observer Variation | 3 | 2014 | 2596 | 0.050 |
Why?
|
| Tendons | 1 | 2006 | 552 | 0.050 |
Why?
|
| Papio papio | 1 | 2021 | 3 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2013 | 6242 | 0.050 |
Why?
|
| Neurofibromin 2 | 1 | 2022 | 270 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2010 | 2825 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2021 | 385 | 0.050 |
Why?
|
| Crohn Disease | 2 | 2011 | 2275 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2015 | 5039 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2013 | 2277 | 0.050 |
Why?
|
| Orthopedic Procedures | 1 | 2010 | 1262 | 0.050 |
Why?
|
| Obesity | 1 | 2022 | 12915 | 0.040 |
Why?
|
| Ovalbumin | 2 | 2013 | 678 | 0.040 |
Why?
|
| Carcinoma, Ductal | 1 | 2020 | 98 | 0.040 |
Why?
|
| Fibroblast Growth Factor 4 | 1 | 2019 | 28 | 0.040 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2020 | 89 | 0.040 |
Why?
|
| Paris | 1 | 2019 | 50 | 0.040 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2021 | 158 | 0.040 |
Why?
|
| Florida | 1 | 2021 | 427 | 0.040 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2020 | 75 | 0.040 |
Why?
|
| Administration, Cutaneous | 2 | 2013 | 711 | 0.040 |
Why?
|
| Pregnancy | 4 | 2022 | 29725 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2022 | 346 | 0.040 |
Why?
|
| Cholera Toxin | 2 | 2013 | 559 | 0.040 |
Why?
|
| Fetal Death | 1 | 2021 | 434 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2014 | 9283 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2730 | 0.040 |
Why?
|
| Consensus | 2 | 2021 | 3106 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2021 | 956 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2022 | 454 | 0.040 |
Why?
|
| Probability | 1 | 2004 | 2476 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2021 | 900 | 0.040 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 2368 | 0.040 |
Why?
|
| Hypocalcemia | 1 | 2020 | 199 | 0.040 |
Why?
|
| Aneuploidy | 1 | 2022 | 551 | 0.040 |
Why?
|
| Multivariate Analysis | 4 | 2014 | 12156 | 0.040 |
Why?
|
| Triazoles | 2 | 2014 | 904 | 0.040 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2020 | 155 | 0.040 |
Why?
|
| Adenomatous Polyps | 1 | 2019 | 108 | 0.040 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 3826 | 0.040 |
Why?
|
| Capillaries | 2 | 2019 | 745 | 0.040 |
Why?
|
| Cell Aggregation | 1 | 2018 | 239 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2008 | 1973 | 0.040 |
Why?
|
| Biotinylation | 1 | 1998 | 184 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2006 | 2612 | 0.040 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 18134 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 2558 | 0.040 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2020 | 262 | 0.040 |
Why?
|
| Microsatellite Repeats | 2 | 2012 | 786 | 0.040 |
Why?
|
| Breast | 1 | 2007 | 1980 | 0.040 |
Why?
|
| Antibody Affinity | 1 | 1998 | 245 | 0.040 |
Why?
|
| Prospective Studies | 6 | 2021 | 54263 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 441 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2018 | 14396 | 0.040 |
Why?
|
| Succinic Acid | 1 | 2018 | 84 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 52 | 0.040 |
Why?
|
| Hepatomegaly | 1 | 2017 | 84 | 0.040 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1998 | 419 | 0.040 |
Why?
|
| Knee Joint | 1 | 2006 | 1662 | 0.040 |
Why?
|
| Fumarates | 1 | 2018 | 131 | 0.040 |
Why?
|
| Chemokines | 1 | 2021 | 962 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 1998 | 2262 | 0.040 |
Why?
|
| Animal Feed | 1 | 2017 | 112 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2018 | 280 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2007 | 1915 | 0.030 |
Why?
|
| Prednisone | 2 | 2011 | 1566 | 0.030 |
Why?
|
| Color | 1 | 2018 | 298 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 2018 | 265 | 0.030 |
Why?
|
| Thiolester Hydrolases | 1 | 2017 | 85 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2017 | 189 | 0.030 |
Why?
|
| Phosphates | 1 | 2020 | 771 | 0.030 |
Why?
|
| Pandemics | 3 | 2021 | 8621 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 840 | 0.030 |
Why?
|
| Foot | 1 | 2020 | 573 | 0.030 |
Why?
|
| Anal Canal | 1 | 2019 | 373 | 0.030 |
Why?
|
| Glutarates | 1 | 2018 | 244 | 0.030 |
Why?
|
| Tumor Escape | 1 | 2019 | 371 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 2015 | 45 | 0.030 |
Why?
|
| Computational Biology | 2 | 2018 | 3504 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2024 | 10829 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2023 | 2214 | 0.030 |
Why?
|
| Ampulla of Vater | 1 | 2016 | 147 | 0.030 |
Why?
|
| Infarction | 1 | 2017 | 248 | 0.030 |
Why?
|
| U937 Cells | 1 | 2015 | 262 | 0.030 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2015 | 59 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2021 | 2671 | 0.030 |
Why?
|
| Age Factors | 3 | 2021 | 18415 | 0.030 |
Why?
|
| Epigenomics | 1 | 2021 | 936 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 998 | 0.030 |
Why?
|
| Automation, Laboratory | 1 | 2015 | 103 | 0.030 |
Why?
|
| Cofilin 2 | 1 | 2015 | 12 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 1760 | 0.030 |
Why?
|
| Choline | 1 | 2017 | 513 | 0.030 |
Why?
|
| Penetrance | 1 | 2017 | 388 | 0.030 |
Why?
|
| Neutrophils | 2 | 2021 | 3770 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2015 | 3584 | 0.030 |
Why?
|
| Bone Marrow Examination | 1 | 2015 | 155 | 0.030 |
Why?
|
| Immunotoxins | 1 | 1995 | 175 | 0.030 |
Why?
|
| Mice, Nude | 2 | 1999 | 3605 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 22025 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 1395 | 0.030 |
Why?
|
| Immunoassay | 1 | 1998 | 748 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2018 | 740 | 0.030 |
Why?
|
| Methionine | 1 | 2017 | 569 | 0.030 |
Why?
|
| Syndrome | 2 | 2011 | 3278 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 859 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 1062 | 0.030 |
Why?
|
| Central Nervous System Cysts | 1 | 2014 | 56 | 0.030 |
Why?
|
| Forms and Records Control | 1 | 2015 | 158 | 0.030 |
Why?
|
| Basement Membrane | 1 | 1995 | 348 | 0.030 |
Why?
|
| Transplantation, Homologous | 2 | 2016 | 4814 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 2016 | 480 | 0.030 |
Why?
|
| Transplantation Immunology | 1 | 2016 | 532 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 3726 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 2015 | 175 | 0.030 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2017 | 506 | 0.030 |
Why?
|
| Lung | 1 | 2012 | 9989 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2015 | 614 | 0.030 |
Why?
|
| Antibodies | 2 | 2013 | 2424 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 1349 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 3758 | 0.030 |
Why?
|
| Anti-Allergic Agents | 1 | 2015 | 148 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2018 | 607 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2018 | 8553 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 604 | 0.030 |
Why?
|
| Interleukins | 1 | 2018 | 782 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 1617 | 0.030 |
Why?
|
| Data Mining | 1 | 2018 | 553 | 0.030 |
Why?
|
| Calcinosis | 1 | 2002 | 1478 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 877 | 0.030 |
Why?
|
| Protein Binding | 2 | 2017 | 9336 | 0.030 |
Why?
|
| Brain | 1 | 2020 | 26912 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2008 | 3482 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2014 | 150 | 0.030 |
Why?
|
| Genes, ras | 1 | 2016 | 654 | 0.030 |
Why?
|
| Societies, Medical | 2 | 2015 | 3903 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 1996 | 768 | 0.030 |
Why?
|
| Injections | 1 | 2016 | 830 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2017 | 769 | 0.030 |
Why?
|
| Neurofibromin 1 | 1 | 2014 | 190 | 0.030 |
Why?
|
| Cytological Techniques | 1 | 2014 | 218 | 0.030 |
Why?
|
| Burkitt Lymphoma | 1 | 1995 | 333 | 0.030 |
Why?
|
| Salivary Glands | 1 | 2014 | 229 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 4172 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2015 | 2449 | 0.030 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2012 | 26 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 2178 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 1786 | 0.030 |
Why?
|
| Cromolyn Sodium | 1 | 2012 | 77 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2012 | 6361 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2019 | 1354 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 329 | 0.030 |
Why?
|
| Diaphragm | 1 | 2014 | 351 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2018 | 908 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 197 | 0.020 |
Why?
|
| Monocytes | 1 | 2021 | 2574 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 751 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2014 | 561 | 0.020 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2012 | 131 | 0.020 |
Why?
|
| Purines | 1 | 2015 | 601 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2015 | 615 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2018 | 1739 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2017 | 749 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 642 | 0.020 |
Why?
|
| Epinephrine | 1 | 2015 | 791 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 13456 | 0.020 |
Why?
|
| Vimentin | 1 | 2012 | 255 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2020 | 1159 | 0.020 |
Why?
|
| Buttocks | 1 | 2011 | 111 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2016 | 5960 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 165 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2010 | 5201 | 0.020 |
Why?
|
| Flushing | 1 | 2011 | 52 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 383 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2015 | 564 | 0.020 |
Why?
|
| Reference Standards | 1 | 2015 | 1004 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1998 | 3804 | 0.020 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2011 | 142 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2011 | 220 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2015 | 593 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2608 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2011 | 260 | 0.020 |
Why?
|
| Ifosfamide | 1 | 2011 | 232 | 0.020 |
Why?
|
| Factor VIII | 1 | 2013 | 350 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2017 | 1897 | 0.020 |
Why?
|
| Neurosecretory Systems | 1 | 2012 | 221 | 0.020 |
Why?
|
| Workflow | 1 | 2015 | 851 | 0.020 |
Why?
|
| Adrenal Glands | 1 | 2013 | 556 | 0.020 |
Why?
|
| Depression | 1 | 2010 | 8033 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2010 | 66 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2011 | 278 | 0.020 |
Why?
|
| Cause of Death | 1 | 2021 | 3723 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 607 | 0.020 |
Why?
|
| Lymphoma | 2 | 2016 | 1899 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 10183 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2012 | 469 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 2011 | 315 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2011 | 574 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2016 | 2569 | 0.020 |
Why?
|
| Alphapapillomavirus | 1 | 2013 | 218 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 1998 | 2378 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1135 | 0.020 |
Why?
|
| Hypertension | 1 | 2010 | 8595 | 0.020 |
Why?
|
| Shoulder | 1 | 2012 | 299 | 0.020 |
Why?
|
| Niacinamide | 1 | 2012 | 414 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2011 | 330 | 0.020 |
Why?
|
| Fibrosis | 1 | 2017 | 2042 | 0.020 |
Why?
|
| Desensitization, Immunologic | 1 | 2015 | 532 | 0.020 |
Why?
|
| Receptors, Growth Factor | 1 | 2010 | 326 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 2012 | 575 | 0.020 |
Why?
|
| Body Temperature | 1 | 2013 | 777 | 0.020 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 1030 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2015 | 8314 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2014 | 1697 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2015 | 15766 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2006 | 3604 | 0.020 |
Why?
|
| Vincristine | 1 | 2011 | 1038 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2013 | 1133 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 620 | 0.020 |
Why?
|
| Cervix Uteri | 1 | 2013 | 585 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 1670 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 1996 | 949 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4264 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2012 | 983 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2015 | 2195 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 529 | 0.020 |
Why?
|
| CA-125 Antigen | 1 | 2011 | 280 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2009 | 198 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2013 | 1455 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 358 | 0.020 |
Why?
|
| Fluconazole | 1 | 2009 | 155 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2013 | 770 | 0.020 |
Why?
|
| Logistic Models | 2 | 2016 | 13311 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2011 | 484 | 0.020 |
Why?
|
| International Cooperation | 1 | 2015 | 1436 | 0.020 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2008 | 178 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 1884 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2013 | 1122 | 0.020 |
Why?
|
| Leukemia | 1 | 2016 | 1522 | 0.020 |
Why?
|
| Intestinal Polyps | 1 | 2008 | 104 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 857 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1755 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2014 | 1478 | 0.020 |
Why?
|
| Exanthema | 1 | 2012 | 504 | 0.020 |
Why?
|
| Giant Cells | 1 | 2008 | 185 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 8945 | 0.020 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2012 | 565 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2014 | 2897 | 0.020 |
Why?
|
| Azithromycin | 1 | 2009 | 201 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 2011 | 377 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2009 | 384 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2013 | 3665 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 3601 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2010 | 943 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 1755 | 0.020 |
Why?
|
| Antigens | 1 | 2013 | 1447 | 0.020 |
Why?
|
| Cyclin D | 1 | 2007 | 72 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2852 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5796 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 600 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 317 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2017 | 5429 | 0.020 |
Why?
|
| Dermis | 1 | 2008 | 202 | 0.020 |
Why?
|
| Integrins | 1 | 2011 | 840 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2010 | 567 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2012 | 1633 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 2641 | 0.020 |
Why?
|
| Endometriosis | 1 | 2014 | 871 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 2846 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2011 | 2120 | 0.020 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2008 | 364 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2009 | 778 | 0.020 |
Why?
|
| Phylogeny | 1 | 2013 | 2775 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2698 | 0.020 |
Why?
|
| Lipids | 1 | 2017 | 3336 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2011 | 2220 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 1955 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5201 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 2646 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2007 | 218 | 0.020 |
Why?
|
| Cisplatin | 1 | 2011 | 1642 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2011 | 2207 | 0.020 |
Why?
|
| Chromosomes, Human, 13-15 | 1 | 2004 | 49 | 0.020 |
Why?
|
| Quinazolines | 1 | 2011 | 1363 | 0.020 |
Why?
|
| Cyclins | 1 | 2007 | 593 | 0.010 |
Why?
|
| Subcutaneous Fat | 1 | 2008 | 393 | 0.010 |
Why?
|
| CpG Islands | 1 | 2009 | 1221 | 0.010 |
Why?
|
| Monosomy | 1 | 2004 | 52 | 0.010 |
Why?
|
| Antigens, CD1 | 1 | 2007 | 439 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2012 | 1112 | 0.010 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2009 | 664 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 2204 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2009 | 746 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2011 | 1738 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1833 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 1870 | 0.010 |
Why?
|
| Placebos | 1 | 2008 | 1672 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 865 | 0.010 |
Why?
|
| Cell Line | 2 | 2014 | 15626 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 616 | 0.010 |
Why?
|
| Methylation | 1 | 2006 | 1080 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2011 | 4044 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2011 | 2937 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 3448 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2011 | 1666 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 1134 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2011 | 1089 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 568 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2011 | 2143 | 0.010 |
Why?
|
| Activin Receptors, Type I | 1 | 2002 | 136 | 0.010 |
Why?
|
| Activin Receptors, Type II | 1 | 2002 | 123 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2009 | 982 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2013 | 3293 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2013 | 3023 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9531 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2866 | 0.010 |
Why?
|
| Alleles | 1 | 2011 | 6900 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2009 | 1589 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 2651 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 5206 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 1799 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 11902 | 0.010 |
Why?
|
| Diet | 1 | 2017 | 8008 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10530 | 0.010 |
Why?
|
| Communicable Diseases | 1 | 2007 | 879 | 0.010 |
Why?
|
| Genome | 1 | 2006 | 1739 | 0.010 |
Why?
|
| Cytokines | 1 | 2013 | 7345 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7468 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 3335 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2009 | 9712 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 2696 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 4168 | 0.010 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1996 | 303 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 21378 | 0.010 |
Why?
|
| Homeostasis | 1 | 2006 | 3305 | 0.010 |
Why?
|
| Disease Management | 1 | 2003 | 2508 | 0.010 |
Why?
|
| Drug Carriers | 1 | 1995 | 706 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 7400 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 12447 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 17628 | 0.000 |
Why?
|